Three Questions with Gabriel Hasson
Governance has moved from the sidelines of corporate strategy to its center. In a recent conversation with Insightia, Gabriel Hasson,...
Who Controls the AI Risk Narrative
I was in a meeting recently when a CEO asked me something I’ve kept turning over since. Roughly: every major...
Is Berachain’s Model Built to Last?
I recently sat down with Jason Hitchcock, CEO of Greenlane Holdings (Nasdaq: GNLN), to discuss what he believes is a...
Welcome to the Arena: Josh Charlesworth
Krispy Kreme has built a global brand on the strength of their incredible donuts. But the brand has recently gone...
Welcome to the Arena: Peter Milner
Millions of people around the world suffer from gastrointestinal issues like gastroparesis, reflux, and constipation. But until now, the available...
Tariff Dispute and SEC Reforms
Washington was active on multiple fronts this month. New tariffs on dozens of countries, including Canada and Brazil, are reshaping...
Welcome to the Arena: Ramy Brook
So many women’s clothing companies are all about fast fashion: trendy products that are made to sell, but not to...
Welcome to the Arena: Enhanced
The health and wellness space is crowded, with a lot of companies selling products that they claim will keep you...
Welcome to the Arena: Reversing Type 2 Diabetes
The medical establishment spent decades telling patients that type 2 diabetes is a chronic and irreversible disease. Today’s guest decided...
Tariffs, SEC and China Moves
This month, we cover a new round of global tariffs affecting dozens of trading partners, additional duties on Canada and...
